Your browser doesn't support javascript.
loading
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer.
Shore, Neal D; Tutrone, Ronald F; Mariados, Neil F; Nordquist, Luke T; Mehlhaff, Bryan A; Steere, Karyn J; Harrelson, Stacey S.
Affiliation
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC. Electronic address: nshore@gsuro.com.
  • Tutrone RF; Chesapeake Urology Research Associates, Towson, MD.
  • Mariados NF; Associated Medical Professionals of New York, Syracuse, NY.
  • Nordquist LT; GU Research Network, Omaha, NE.
  • Mehlhaff BA; Oregon Urology Institute, Springfield, OR.
  • Steere KJ; Steere and Associates, LLC, St Paul, MN.
  • Harrelson SS; Carolina Urologic Research Center, Myrtle Beach, SC.
Clin Genitourin Cancer ; 16(2): 149-154, 2018 04.
Article in En | MEDLINE | ID: mdl-29196208

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisone / Radium / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Clinical_trials / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisone / Radium / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Clinical_trials / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2018 Type: Article